The Column Group II, LP 13D/13G Filings for Arcus Biosciences, Inc. (RCUS)

The Column Group II, LP 13D and 13G filings for Arcus Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2020-11-04
4:52 pm
Sale		 2020-08-20 13G Arcus Biosciences, Inc.
RCUS		 The Column Group II, LP 0
0.000%		 -3,540,850decrease
(Position Closed)		 Filing